息肉样脉络膜血管病变的治疗进展
摘要
常见原因，严重影响患者的健康和生活质量。本文就息肉样脉络膜血管病变的发病机制、临床特征、治疗等方面进行分析，
为息肉样脉络膜血管病变的诊断、治疗和预后评价提供依据。
关键词
全文:
PDF参考
[1]Tanaka K, Nakayama T, Mori R,Sato N, Kawamura A, Mi-
zutani Y，et al. Associations of complement factor H and ARMS2
genotypes with subtypes of polypoidal choroidal vasculopathy. In-
vest Ophthalmol Vis Sci 2011，52（10）: 7441–7444.
[2]Bessho H, Honda S, Kondo N,Kusuhara S, et al .the asso-
ciation of age-related maculopathy susceptibility 2 polymorphisms
with phenotype in typical neovascular age-related macular de-
generation and polypoidal choroidal vasculopathy.MOLECULAR
VISION 2011,17（108）：977-982
[3]Koji Tanaka, Tomohiro Nakayama, Ryusaburo Mori.As-
sociations of complement factor B andcomplement component 2
genotypes with subtypes of polypoidal choroidal vasculopathy.
BMC Ophthalmology 2014, 14:83
[4]Sachiko Kuroiwa,Hisashi Tateiwa,Toshio Hisatomi，et
al.Pathological features of surgically excised polypoidal choroidal
vasculopathy membranes.Clinical & Experimental Ophthalmology
2004,32(3):297-302
[5] 刘刚 ，孙勇 ，秦艳丽 . 息肉状脉络膜血管病变的临
床特征分析 . 临床眼科杂志 2012 ,20(6):503-507
[6] 王 怀 华， 曾 繁 星， 孙 晓 蕾， 陈 秀 丽， 徐 海 峰 . 息
肉样脉络膜血管病变的临床特征 [J]. 眼科新进展 2013,33
（3）:282-285.
[7] 刘雪霞 . 息肉样脉络膜血管病变的诊断与治疗进
展 . 中华眼科学学杂志 2013 ， 3（3）：173-174
[8]Uyama M，Wada M，Nagai Y，et al． Polypoidal cho-
roidal vasculopathy: natural history． Am J Ophthalmol，2002，
133（5）: 639-648
[9]Akiyuki Kawamura,Mitsuko Yuzawa,Ryusaburo Mori,et
al.Indocyanine green angiographic and optical coherence tomo-
graphic findings support classification of polypoidal choroidal vas-
culopathy into two types.Acta Ophthalmologica 2013,91(6):e474-
481
[10]Takanori Kameda,Akitaka Tsujikawa,Atsushi Otani,et
al.Polypoidal choroidal vasculopathy examined with en face opti-
cal coherence tomography.Clinical & Experimental Ophthalmology
2007,35(7):596-601.
[11]Tomiyasu Taneto,Nozaki Miho,Yoshida Munenon,et
al.characteristics of polypoidal choroidal vasculopathy evaluated
by optical coherence tomography.INVESTIGATIVE OPHTHAL-
MOLOGY & VISUAL SCIENCE 2016,57(9):OCT324-OCT330
[12]Akiko Okubo,Noboru Arimura,Noriko Abematsu,et
al.Predictable signs of benign course of polypoidal choroidal vas-
culopathy: based upon the long-term observation of non-treated
eyes.Acta Ophthalmologica2010,88(4):e107-114
[13]Francesco Bozzoni Pantaleoni,Vittoria Magliari
Galante,Stefano Da Dalt,et al.Localizing polypoidal choroi-
dal vasculopathy for laser treatment.Acta Ophthalmologica
2007,88(4):456-458
[14]Yuzawa M,Mori R,Haruyama M,et al.a study of laser
photocoagulation for polypoidal choroidal vasculopathy.JAPA-
NESE JOURNAL OF OPHALMOLOGY 2003,47(4):379-384
[15]Newman.Photodynamic therapy: current role in the treat-
ment of chorioretinal conditions.EYE 2015,30(2):202-210
[16]Hirami Y, Tsujikawa A, Otani A ,et al .(2007) Hemor-
rhagic complications after photodynamic therapy for polypoidal
choroidal vasculopathy. Retina 2007,27(3):335–341 .
[17] 胡忆群，陈青山，方 敏，佘洁婷，杨 旭 . 玻璃体
腔注射 抗 -VEGF 联合黄斑格栅样光凝治疗 DM E 的临床观
察 [J]. 国际眼科杂志 2012；12(1):36-38.
[18]Kohno Ri-ichiro,Hata Yasuaki,Mochizuki Yasutaka ,et
al.Histopathology of Neovascular Tissue From Eyes with Prolifo-
rative Diabetic Retinopathy After Intravitreal Bevacizumab In-
jection[J].AMERICAN JOURNAL OF OPHTHALMOLOGY 2010
.150(2):223-231.
[19]EL Matri, Leila,Chebil Ahmed,et al.Curret and emerging
treatment option for myopic choroidal neovasculation.CLINICAL
OPHTHALMOLOGY 2015,9:733-744
[20]Koizumi,Hideki,Kano,et al.aflibercept therapy for
polypoidal choroidal vasculopathy:short-term results of a mul-
ticentre study.BRITISH JOURNAL OF OPHTHALMOLOGY
2015,253(9):1471-1477
[21]Inoue,Maiko,Yamane,et al.aflibercept for polypoidal cho-
roidal vasculopathy as needed versus fixed interval doing.RETI-
NA-THE JOURNAL OF RETINAL AND VITROUS DISEASES
2016.36（8）：1527-1534
[22]Inoue M,Arakawa A,Yamane S,et al.VARIABLE RE-
SPONSE OF VASCULARIZED PIGMENT EPITHELIAL
DETACHMENTS TO RANIBIZUMAB BASED ON LESION
SUBTYPES INCLUDING POLYPOIDAL CHOROIDAL VASCU-
LOPATHY.RETINA-THE JOURNAL OF RETINAL AND VIT-
REOUS DISEASES 2013,33(5):990-997
[23]Lin Chun-Ju,Tsai,Yi Yu.The effect of intravitreal beva-
cizumab and transpupillary thermotherapy on choroidal metastases
and literature review.INDIAN JOURNAL OF OPHTHALMOLO-
GY 2015,63(1):37-41.
[24]V Vedantham,C Kolluru,K Ramasamy,et al.treatment of
polypoidal choroidal vasculopathy with transpupillary thermother-
apy: an inteventional case report.Eye 2005,19(8)：915–917
[25]Mitamura,Kubota-Taniai,Okada,et al;comparision of
photodynamic therapy to transpupillary thermotherapy for poly-
poidal choroidal vasculopathy.Eye 2009 ,23(1):67–72
[26]Frau E,Rumen F,Noel G,et al .low-dose proton beam
therapy for circumscribed choroidal hemangiomas.ARCHIVES OF
PPHTHALMOLOGY 2004,122(10):1471-1475
[27]Shozo Sonoda, Taiji Sakamoto, Hiroki Otsuka, et al.Re-
sponsiveness of eyes with polypoidal choroidal vasculopathy with
choroidal hyperpermeability to intravitreal ranibizumab .BMC
Ophthalmology 2013，13(43):548-556 .
[28]Tsutomu sakai,Kiichiro Okano,Hideo Kohno,et al.
Three-year visual outcomes of intravitreal ranibizumab with or
without photodynamic therapy for polypoidal choroidal vasculopa-
thy.Acta Ophthalmologica 2016;94(8):e765-e771
[29]Liu Hui,Zhang Lu-yi,Li Xiao-xia,et al.23-gauge vit-
rectomy with external drainage therapy as a novel procedure to
displace massive submacular hemorrhage secondary to polypoidal
choroidal vasculopathy.MEDICINE 2016,95(32):e119-e121
[30]Narayanan,Raja,Mithal,et al.vitreous haemorrhage in
massive hemorrhagic polypoidal choroidal vasculopathy:clinical
characteristics and surgical outcomes :vitreous hemorrhage in
PCV.International journal of retina and vitreous2015,1:25
[31]Osterholm Cecilia,Li Shushun,Ekberg Henrik,downreg-
ulation of tissue factor(TF) by RNA interference induces apoptosis
and impairs cell survival of primary endothelium and tumor cells.
CELL AND TISSUE RESEARCH 2008,334(1):93-102.
[32]Olejniczak M,Urbanek MO,Jaworska E,et al.se-
quence-non-specific effects generated by various types of RNA
interference triggers.BIOCHIMICA ET BIOPHYSICA AC-
TA-GENE REGULATORY MECHANISMS 2015,1859(2):306-
314
[33]Wang Wei,Matsukura Makoto,Fujii Isao,et al.inhibi-
tion of high glucose-induced VEGF and ICAM-1 expression in
human retinal pigment epithelium cells by targeting ILK with
small interference RNA.MOLECULAR BIOLOGY REPORTS
2012,39(1):613-620
(2 摘要 Views, 1 PDF Downloads)
Refbacks
- 当前没有refback。